Physician profile
Apurva Patel
NPI 1720424542
$2,764.80
in general payments reported to CMS, 2019-2025
18 companies · $379 in 2025
The $379 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $291 · 2020: $206 · 2021: $450 · 2022: $754 · 2023: $330 · 2024: $354 · 2025: $379.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,012 · Education: $51.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,011.77 |
| Education | $51.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $526.33 | 2022 | |
| Cvrx, INC. | $383.96 | 2022-2025 | Barostim Neo System |
| Boston Scientific Corporation | $356.33 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor |
| Medtronic, INC. | $331.60 | 2021-2022 | |
| Abiomed | $182.58 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $177.32 | 2022-2025 | Verquvo |
| Medtronic Vascular, INC. | $153.17 | 2020 | |
| Novo Nordisk INC | $136.82 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $96.84 | 2021-2025 | Lifevest |
| Amgen INC. | $81.06 | 2021-2025 | Repatha, Repatha |
| Cleerly, INC. | $64.29 | 2025 | Cleerly Ischemia, Cleerly Labs |
| E.R. Squibb & Sons, L.L.C. | $64.04 | 2023 | Eliquis, Camzyos |
| Pfizer INC. | $58.45 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $56.81 | 2024-2025 | |
| Chiesi USA, INC. | $46.74 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $17.62 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.87 | 2023 | Jardiance |
| Scpharmaceuticals INC. | $14.97 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Apurva Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.